Buy the Dip on This Pharma Stock

INVA shares shed 17.3% last week, but could find familiar support

by Patrick Martin

Published on Feb 7, 2019 at 2:39 PM
Updated on Feb 7, 2019 at 2:39 PM

Few stocks have had as rough a start to February as Innoviva Inc (NASDAQ:INVA). The pharma name shed 17.3% last week alone, and has extended those struggles to this week. However, this pullback, if history is any guide, could present a buying opportunity for INVA bulls. 

More specifically, Innoviva stock is now trading within one standard deviation of its 320-day moving average. The last nine times INVA pulled back to this moving average after a lengthy stretch above it, the equity was up 4.9%, on average, one month out, per data from Schaeffer's Senior Quantitative Analyst Rocky White.

At last check, Innoviva stock was up 1.9% to trade at $15.67, erasing early post-earnings losses. The stock is also shrugging off a price-target cut to $22 from $23 at Berenberg. What's more, INVA's 14-day Relative Strength Index (RSI) was docked at 27 at Wednesday's closing bell -- well into oversold territory, leaving the security well-positioned to bounce in the short term.

Daily Stock Chart INVA

For a stock that nabbed a three-year high of $20.54 as recently as Jan. 30, INVA is represented well among short sellers. The 17.97 million shares sold short is the most since April 2017, and represents a whopping 27% of the equity's total available float. Should the security start to climb again, it would take shorts nearly 16 days to buy back their bearish bets, at INVA's average daily trading volume.


a schaeffer's exclusive

5 NEW STOCK PICKS

We're celebrating 38 years with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.
2 Semiconductor Stocks Raymond James is Buying
The chip stocks look attractive to the brokerage firm, despite trade-related risk
Analysts Expect MYOV, NCNA Stocks to Triple
The biopharma stocks are higher on new bullish analyst ratings
IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.